Prosecution Insights
Last updated: November 04, 2026

Vos-Ip, LLC

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

6 pending office actions • 5 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready

Analysis

Vos-IP, LLC operates in the Biotechnology & Pharmaceuticals technology area with 328 career applications. The firm has a resolved allowance rate of 82.09 percent. Prosecution involves an average of 3.42 office actions per allowance. These statistics provide a baseline for understanding the firm's historical performance in its primary field of practice and its success in securing patent protections.

There are 5 pending office actions currently being handled by the firm. The 82.09 percent allowance rate and 3.42 average office actions per allowance define the firm's historical performance across 328 career applications. These figures provide a baseline for clients in the Biotechnology & Pharmaceuticals sector. This data is essential for evaluating the firm's experience and the expected procedural requirements for new patent applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=329 apps, methodology: how we score firms)

81.9%
Allowance Rate
n=329
+0.60σ
Allowance Rate (norm)
n=329
3.4
OAs to Allowance
n=167
-0.18σ
OAs to Allow (norm)
n=167
774 days
Time to Allowance
n=167
+13.3pp
Interview Lift
n=329
25.5%
RCE Rate
n=329
0.0%
Appeal Rate
n=329

Rejection Performance (% of received rejections ultimately overcome)

60.0%
§101 Overcome
n=25
74.3%
§102 Overcome
n=74
70.7%
§103 Overcome
n=140
78.0%
§112 Overcome
n=118

Specialization & Scale

A61K, G06Q, A61P
Top CPC Subclasses
21%
Top-3 CPC Share
n=329
0
Practitioners
n=329
—
Apps / Practitioner
n=329 (min 20)

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (67%)
2
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (17%)
Double-patenting + other1 (17%)
Multi-statute (no §101)4 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
33% of docket
1
Information Tech
17% of docket
0
Communications
0% of docket
1
Semiconductors
17% of docket
2
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MCPHERSON, JAMES M 1 82.3% +17.2%
STEINKE, SEAN JAMES 1 11.8% +43.3%
GINGRICH, SHADAN HAGHANI 1 61.8% +17.2%
PACHECO, ALEXIS BOATENG 1 77.7% +12.9%
VASUDEVA, AJAY 1 70.8% +22.7%
BREEN, KIMBERLY CATHERINE 1 23.8% +56.3%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19225100 SENSOR FUSION-BASED EARLY WARNING SYSTEM MCPHERSON, JAMES M —
18853465 STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ERDAFITINIB STEINKE, SEAN JAMES —
18538683 ELECTRICAL CHARGING STORAGE DEVICE PACHECO, ALEXIS BOATENG —
18562952 AN UNDERWATER PROBE OR SUBMERSIBLE VASUDEVA, AJAY —
18248392 COLLAGEN BIOMATERIAL BREEN, KIMBERLY CATHERINE —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18850133 VISUAL ANALYZER OF CONFINED PATHWAYS GINGRICH, SHADAN HAGHANI 40d
19225100 SENSOR FUSION-BASED EARLY WARNING SYSTEM MCPHERSON, JAMES M —
18853465 STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ERDAFITINIB STEINKE, SEAN JAMES —
18538683 ELECTRICAL CHARGING STORAGE DEVICE PACHECO, ALEXIS BOATENG —
18562952 AN UNDERWATER PROBE OR SUBMERSIBLE VASUDEVA, AJAY —
18248392 COLLAGEN BIOMATERIAL BREEN, KIMBERLY CATHERINE —

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
36631
16191
24851
28591
36151
16571

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19225100 SENSOR FUSION-BASED EARLY WARNING SYSTEM J Humble & A Muthiah MCPHERSON, JAMES M 3663 §102§103 Non-Final OA — Pending Jun 02, 2025
18853465 STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ERDAFITINIB Natco Pharma Limited STEINKE, SEAN JAMES 1619 §103§112 Non-Final OA — Pending Oct 02, 2024
18850133 VISUAL ANALYZER OF CONFINED PATHWAYS UAM Tec Pty Ltd GINGRICH, SHADAN HAGHANI 2485 §103 Final Rejection 40d Pending Sep 24, 2024
18538683 ELECTRICAL CHARGING STORAGE DEVICE Ampicity, Inc. PACHECO, ALEXIS BOATENG 2859 §102§103 Non-Final OA — Pending Dec 13, 2023
18562952 AN UNDERWATER PROBE OR SUBMERSIBLE UAM Tec Pty Ltd VASUDEVA, AJAY 3615 §102§103§112 Non-Final OA — Pending Nov 21, 2023
18248392 COLLAGEN BIOMATERIAL Hide Biotech Ltd. BREEN, KIMBERLY CATHERINE 1657 §103§112DP Final Rejection — Pending Apr 10, 2023

Managing Vos-Ip, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Vos-Ip, LLC's patent allowance rate?

81.9% of resolved applications prosecuted by Vos-Ip, LLC were allowed, across 329 applications in USPTO records.

How many office actions does Vos-Ip, LLC average before allowance?

3.39 office actions per allowed application on average.

How many pending office actions does Vos-Ip, LLC have?

6 pending office actions as of November 2026, for 5 clients, before 6 examiners in 6 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month